Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Oronsky

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Cellular and Molecular Medicine|July 17, 2018
Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001Bryan Oronsky, Neil Oronsky, Pedro Cabrales
Anti-Cancer Agents in Medicinal Chemistry|June 5, 2014
Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessmentBryan Oronsky, Neil Oronsky, Susan Knox, et al.
Translational Oncology|April 16, 2014
The implications of hyponitroxia in cancerBryan Oronsky, Gary R Fanger, Neil Oronsky, et al.
Translational Oncology|November 13, 2014
Rewriting the epigenetic code for tumor resensitization: a reviewBryan Oronsky, Neil Oronsky, Jan Scicinski, et al.
Discovery Medicine|May 28, 2016
RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cellsBryan Oronsky, Jan Scicinski, Tony Reid, et al.
Oncotarget|January 28, 2016
Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapyBryan Oronsky, Corey Carter, Anna Scicinska, et al.
Neoplasia (New York, N.Y.)|December 12, 2017
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A ReviewBryan Oronsky, Patrick Ma, Tony R Reid, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 8, 2014
Follow the ATP: tumor energy production: a perspectiveBryan T Oronsky, Neil Oronsky, Gary R Fanger, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and managementBryan Oronsky, Scott Caroen, Arnold Oronsky, et al.
Case Reports in Oncology|May 18, 2017
Cushing's Syndrome, Cortisol, and Cognitive Competency: A Case ReportNeil Oronsky, Bennett Thilagar, Carolyn M Ray, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Cellular and Molecular Medicine|July 17, 2018
Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001Bryan Oronsky, Neil Oronsky, Pedro Cabrales
Anti-Cancer Agents in Medicinal Chemistry|June 5, 2014
Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessmentBryan Oronsky, Neil Oronsky, Susan Knox, et al.
Translational Oncology|April 16, 2014
The implications of hyponitroxia in cancerBryan Oronsky, Gary R Fanger, Neil Oronsky, et al.
Translational Oncology|November 13, 2014
Rewriting the epigenetic code for tumor resensitization: a reviewBryan Oronsky, Neil Oronsky, Jan Scicinski, et al.
Discovery Medicine|May 28, 2016
RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cellsBryan Oronsky, Jan Scicinski, Tony Reid, et al.
Oncotarget|January 28, 2016
Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapyBryan Oronsky, Corey Carter, Anna Scicinska, et al.
Neoplasia (New York, N.Y.)|December 12, 2017
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A ReviewBryan Oronsky, Patrick Ma, Tony R Reid, et al.
Anti-Cancer Agents in Medicinal Chemistry|August 8, 2014
Follow the ATP: tumor energy production: a perspectiveBryan T Oronsky, Neil Oronsky, Gary R Fanger, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and managementBryan Oronsky, Scott Caroen, Arnold Oronsky, et al.
Case Reports in Oncology|May 18, 2017
Cushing's Syndrome, Cortisol, and Cognitive Competency: A Case ReportNeil Oronsky, Bennett Thilagar, Carolyn M Ray, et al.
Pageof 3